3rd Annual Oncology Market Access

• Understand changing stakeholder perspectives: hear from payers, patient groups and regulators.
• Learn how to differentiate targeted therapies - make sure you know how to identify and communicate the value of your product.
• Get to grips with changing perceptions of product value. Increase access and reimbursement by understanding your stakeholders.

Drive therapy access in a challenging environment: Map your route to Market growth and Product Success.

The US Oncology environment is changing. Opportunities for growth are tempered with a host of complex payer and regulatory issues which must be navigated in order to achieve the success available.

eyeforpharma's 2012 US Oncology event has been designed to map up these challenges so they won’t trip up your route to growing your market share.

Targeted therapy commercial success:

Get to grips with the differences in marketing targeting therapies.

Identifying a selected population is a different challenge. Understand different methods of finding your selected population and learn how a new stakeholder, Specialty Pharmacies can help you.

Communicating the value of your targeted therapy is essential to gaining reimbursement. You need to identify what value means to patients, payers and oncologists and make sure that you can differentiate your product to them from competitor therapies.

This summit will address each issue – make sure you give your targeted therapy the perfect commercial platform.

Effective Engagement of the Key Stakeholder: The Patient

As the patient takes a greater involvement in their care your successful engagement with their perspective will become a crucial part of therapy success.

Getting a deeper understanding of the issues facing patient groups and patients will give you the tools to collaborate from development to product launch.

Hear from Patient groups and learn how to work together.

Companion Diagnostics: Marketing, Pricing and Reimbursement.

The emergence of this new technology has brought as many questions as opportunities.

How will this impact therapy marketing? How should I collaborate with developers? How does the approval process differ? How do I engender patient understanding of assay value?

Sound familiar?

We will tackle and address each question – giving you the knowledge to seize the opportunities.

Defining the Value of Treatment

Value perception is changing. Regulators and payers alike face budgetary pressures and the cost of treatment is escalating. Understanding what value means and where your therapy delivers this will be essential in preparing both marketing and access strategies.

Make sure you’re prepared.

Have we got your attention? Great... now read about the agenda in a bit more detail!

Thanks,

Thomas Disley

Global Events Director, Oncology Market Access,
eyeforpharma

T: +44 (0) 207 375 7583

Toll Free: 1800-814-3459 ext. 7592

E: tdisley@eyeforpharma.com

"Excellent platform for debating the issues & opportunities"